http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101722547-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101722547-B1 |
| titleOfInvention | Anti-cancer adjuvant comprising panaxadiols compound |
| abstract | The present invention relates to an anti-cancer adjuvant comprising, as an active ingredient, PPD (protopanaxadiol) or Compound-K, which is a kind of paraxaxidol ginsenoside, and an anti-cancer adjuvant and an anticancer agent exhibiting mitochondrial- To a pharmaceutical composition. Since the anticancer adjuvant comprising the PPD or Compound-K as an active ingredient provided in the present invention damages mitochondria in cancer cells and can assist mitochondrial mediated anti-cancer activity, more safe cancer using anticancer agents showing mitochondrial mediated anti- It can be widely used for the treatment or improvement of diseases. |
| priorityDate | 2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.